Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

PSM Inhibitors

The chemical class of PSM inhibitors encompasses a diverse array of compounds targeting various cellular processes and signaling pathways. These inhibitors exert their effects through distinct mechanisms, providing valuable tools for elucidating the regulatory networks governing PSM expression and function. Bafilomycin A1, for instance, disrupts lysosomal acidification by inhibiting vacuolar-type H+-ATPase (V-ATPase), impacting PSM modulation through lysosome-related pathways. Salubrinal selectively inhibits eukaryotic initiation factor 2 alpha (eIF2α) dephosphorylation, inducing endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), contributing to the modulation of PSM levels. Spautin-1, as a deubiquitinase inhibitor, enhances the degradation of specific substrates through the ubiquitin-proteasome system, influencing the turnover of PSM or related proteins. Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, affects multiple cellular processes, influencing the signaling cascades that modulate PSM expression or activity. Dynasore, a dynamin inhibitor, disrupts endocytic processes, impacting the internalization and trafficking of membrane-associated proteins like PSM.Rapamycin, an mTOR inhibitor, modulates various cellular processes, including autophagy and protein synthesis, influencing the expression or turnover of PSM. 2-Deoxyglucose, a glycolysis inhibitor, induces metabolic stress and activates AMP-activated protein kinase (AMPK), impacting cellular signaling pathways related to PSM expression or function. ML-7, an inhibitor of myosin light chain kinase (MLCK), influences cellular processes related to actin organization, affecting the subcellular localization or function of PSM through cytoskeletal modulation. MG-132, a proteasome inhibitor, blocks proteasomal degradation, leading to the accumulation of ubiquitinated proteins and affecting the turnover of PSM or its interacting partners. NSC 23766, a Rac1 inhibitor, impacts cellular processes related to actin organization, influencing the subcellular localization or function of PSM. In conclusion, the chemical class of PSM inhibitors provides a powerful toolkit for dissecting the intricate regulatory mechanisms governing PSM dynamics within the cellular milieu.

Items 11 to 17 of 17 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore is a small molecule inhibitor of dynamin, a GTPase involved in clathrin-mediated endocytosis. By inhibiting dynamin, Dynasore disrupts endocytic processes, potentially impacting the internalization and trafficking of membrane-associated proteins like PSM.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR), a central regulator of cell growth and proliferation. By inhibiting mTOR, Rapamycin can influence various cellular processes, including autophagy and protein synthesis, potentially modulating the expression or turnover of PSM.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

2-Deoxy-D-glucose is a glucose analog that competitively inhibits glycolysis. By interfering with glycolytic processes, 2-Deoxyglucose induces metabolic stress and activates AMP-activated protein kinase (AMPK), potentially impacting cellular signaling pathways related to PSM expression or function.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML-7 is an inhibitor of myosin light chain kinase (MLCK), which plays a role in the regulation of actin cytoskeleton dynamics. By inhibiting MLCK, ML-7 can influence cellular processes related to actin organization, potentially affecting the subcellular localization or function of PSM through cytoskeletal modulation.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a potent proteasome inhibitor that blocks the activity of the 26S proteasome complex. By inhibiting proteasomal degradation, MG-132 can lead to the accumulation of ubiquitinated proteins, potentially affecting the turnover of PSM or its interacting partners through the ubiquitin-proteasome system.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

NSC 23766 is a selective inhibitor of Rac1, a member of the Rho family of small GTPases involved in cytoskeletal dynamics. By inhibiting Rac1, NSC 23766 can impact cellular processes related to actin organization, potentially influencing the subcellular localization or function of PSM through cytoskeletal modulation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB-203580 is a specific inhibitor of p38 mitogen-activated protein kinase (MAPK), a signaling molecule involved in stress response pathways. By inhibiting p38 MAPK, SB-203580 can modulate cellular responses, potentially influencing the regulation of PSM through stress-related signaling cascades.